SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Teslas long-delayed Roadster reveal dominates discussion, with traders split between excitement over its technology and skepticism that the event will deliver more than a sell-the-news reaction. Some also speculate about a TeslaSpaceX merger, but no deal is confirmed.

SK hynix, Inc. engages in the design, manufacture, and sale of semiconductor products. Its products include dynamic random access memory, not-AND flash memory, and multi-chip package. The company was founded on October 15, 1949 and is headquartered in Icheon, South Korea.

SK Hynix Inc - ADR

SK Hynix is caught in a memory-stock and South Korean market selloff, as traders weigh Chinas CXMT progress against concerns about AI spending, foreign investor outflows and higher-rate pressures. The community is split between viewing the competitive threat and selling as overdone, with some buying the dip, and expecting further downside amid uncertainty about memory demand and pricing.

iShares Trust - iShares Semiconductor ETF

iShares Semiconductor ETF

SOXX is drawing attention after an extended semiconductor selloff, as traders debate whether AI infrastructure spending and financing risks can deliver adequate returns, with inflation and rate concerns adding pressure. The community is split between expecting further declines and viewing the sharp drop and losing streak as an oversold dip-buying opportunity.

Dell Technologies, Inc. is a technology company, providing customers with a broad and innovative solution portfolio to help customers modernize their information technology (IT) infrastructure, address workforce transformation, and offer critical solutions that keep people and organizations connected. It operates through the following segments: Infrastructure Solutions Group (ISG) and Client Solutions Group (CSG). The ISG segment includes servers, networking, and storage, as well as services and third-party software and peripherals that are closely tied to the sale of ISG hardware. The CSG segment includes designs for commercial and consumer customers of desktops, thin client products, and notebooks. The company was founded by Michael Saul Dell in 1984 and is headquartered in Round Rock, TX.

Dell Technologies Inc - Ordinary Shares - Class C

Dell Technologies Inc

Dells sharp selloff is being tied mainly to Barclays downgrade of Dell and other enterprise hardware names, citing limited evidence of accelerating enterprise AI spending and concerns that higher memory pricesnot stronger unit demandhave driven revenue growth. Traders are split between calling the drop an overreaction and buying the dip, and arguing that rich valuations and doubts about AI infrastructure demand leave further downside risk.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

A broad selloff in memory and semiconductor stocks has weighed on SanDisk amid worries about AI infrastructure financing, Chinese competition, and higher borrowing costs. Traders are split between buying the sharp pullback ahead of earnings and warning that AI spending and memory-sector valuations may face further pressure.

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.

Merck & Co Inc

Merck is drawing attention after its and Modernas personalized cancer vaccine, used with Keytruda, met key Phase 3 endpoints in melanoma, prompting optimism about the oncology pipeline and renewed debate over the treatments potential beyond melanoma. Traders are split on whether the rally is justified, with some flagging valuation and the need for fuller trial data and regulatory progress.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Discussion is dominated by backlash to Trump administration headlines, especially reports of restrictions on Ukraines Starlink and intelligence support, alongside concerns about the Iran conflict, energy costs, and inflation. Many traders see the political and economic backdrop as bearish for DJT ahead of the midterms, while a smaller bullish camp cites speculation about a TAE fusion deal and a potential rebound.

Nokia Oyj engages in the provision of network infrastructure, technology, and software services. It operates through the following segments: Mobile Networks, Network Infrastructure, Cloud and Network Services, and Nokia Technologies. The Mobile Networks segment offers technologies for Radio Access Networks (RAN) as well as Microwave Radio Links (MWR) for transport networks. The Network Infrastructure serves communication service providers, enterprises, webscales and public sector customers. The Cloud and Network Services segment builds around software and the cloud and is focused on driving leadership in cloud-native software and as-a-service delivery models, as demand for critical networks accelerates; and with strong market positions in communications software, private wireless networks, and cognitive (or intelligent) services. The Nokia Technologies segment, building on decades of innovation and R&D leadership in technologies used in virtually all mobile devices used today, is expanding the Nokia patent licensing business, reintroducing the Nokia brand to smartphones through brand licensing, and establishing a technology licensing business. The company was founded by Fredrik Idestam in 1865 and is headquartered in Espoo, Finland.

Nokia Corp - ADR

Nokia Corp

Nokias AI-infrastructure story is driving attention, with traders citing data-center networking demand, its NVIDIA collaboration and CEO comments on strong demand as reasons to expect growth ahead of Q3 results. Sentiment is divided: some anticipate a re-rating, while others are frustrated that the shares have struggled to hold gains and want earnings to confirm the story.

Atlassian Corp. is a holding company, which engages in providing team collaboration and productivity software. Its products include Jira Software, Confluence, Jira Service Management, and Loom. The company was founded by Michael Cannon-Brookes and Scott Farquhar in October 2002 and is headquartered in San Francisco, CA.

Atlassian Corporation - Ordinary Shares - Class A

Atlassian Corporation Plc

Atlassians strong quarterly results and cloud outlook sparked a sharp rally, with traders viewing the performance as evidence that AI may complement rather than displace its software business and helping revive optimism in SaaS. Bulls are celebrating the rebound, while others warn the move may be overextended and expect profit-taking or a pullback.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bull 3X ETF

Direxion Daily Semiconductor Bull 3X Shares

A sharp semiconductor-sector selloff, fueled by hotter inflation concerns and doubts about AI spending, valuations, and Chinese competition, is driving attention to SOXLs amplified swings. Traders are split between expecting more downside and buying an oversold dip, pointing to continued chip demand and upcoming semiconductor earnings as reasons for a possible rebound.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

AI in Drug Discovery Market Projected to Reach $8.52 Billion By 2030

AI in Drug Discovery Market Projected to Reach $8.52 Billion By 2030 AI in Drug Discovery Market Projected to Reach $8.52 Billion By 2030 PR Newswire AUSTIN, Texas, Sept. 3, 2026 AUSTIN, Texas, Sept. 3, 2026 /PRNewswire/ -- Equity Insider News Commentary - Pharmaceutical research is being rebuilt...

Absci (ABSI) Q2 2026 Earnings Call Transcript

@media (max-width: 768px) {
 .image-container {
 width: 100% !important;
 float: none !important;
 margin: 0 0 1rem 0 !important;
 }
 }

Image source: The Mo...

The Zacks Analyst Blog Highlights Recursion Pharmaceuticals, Schrodinger, Relay Therapeutics and Absci

AI is reshaping drug discovery, with Recursion Pharmaceuticals, Schrodinger, Relay Therapeutics and Absci advancing computational platforms and pipelines.

4 AI-Powered Drug Discovery Stocks to Watch as AI Reshapes Pharma

RXRX, SDGR, RLAY and ABSI are using AI-powered platforms to transform drug discovery while advancing proprietary clinical pipelines.

Are Medical Stocks Lagging  ABSCI CORP (ABSI) This Year?

Here is how Absci Corporation (ABSI) and Acadia Healthcare (ACHC) have performed compared to their sector so far this year.

A Small AI Company Just Took the Stage at One of the Biggest Events in Computing, and It Points to Where Drug Discovery Is Headed

A Small AI Company Just Took the Stage at One of the Biggest Events in Computing, and It Points to Where Drug Discovery Is Headed A Small AI Company Just Took the Stage at One of the Biggest Events in Computing, and It Points to Where Drug Discovery Is Headed PR Newswire AUSTIN, Texas, July 24...

Viking Therapeutics to Report Q2 Earnings: What's in Store for the Stock?

VKTX's Q2 report could hinge on VK2735 pipeline updates as investors await progress on obesity studies and maintenance dosing plans.

As AI Rewrites Drug Discovery, This Bio-Native AI Company Just Joined the Russell 3000E, and Reports Earnings July 22

As AI Rewrites Drug Discovery, This Bio-Native AI Company Just Joined the Russell 3000E, and Reports Earnings July 22 As AI Rewrites Drug Discovery, This Bio-Native AI Company Just Joined the Russell 3000E, and Reports Earnings July 22 PR Newswire AUSTIN, Texas, July 15, 2026 Issued on behalf of...

Wall Street Analysts Predict a 28.3% Upside in ABSCI CORP (ABSI): Here's  What You Should Know

The average of price targets set by Wall Street analysts indicates a potential upside of 28.3% in ABSCI CORP (ABSI). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

As AI Models Become Commodities, a Bio-Native AI Company Just Moved to Patent the Data Layer Beneath the Models

As AI Models Become Commodities, a Bio-Native AI Company Just Moved to Patent the Data Layer Beneath the Models As AI Models Become Commodities, a Bio-Native AI Company Just Moved to Patent the Data Layer Beneath the Models PR Newswire AUSTIN, Texas, July 6, 2026 Issued on behalf of MindWalk...

Absci Corp. engages in drug discovery with generative design to create biologics for patients. Its platform combines AI models with a synthetic biology data engine, enabling the design of therapeutics that address challenging therapeutic targets. The firm has its own pipeline of AI designed therapeutics including ABS-201 and ABS-202. Absci Corp was founded by Sean McClain in 2011 and is headquartered in Vancouver, WA.

Absci Corp

Why Did UAL, GLW, ABSI Stocks Surge To 52-Week Highs Today? 

Equity

Bearish Sentiment

50bps hike

25bps hike

No change

Rate cut

September CPI rose 0.6% from the prior month to 3.7% annually, while producer prices jumped 6.3% year-over-year, the biggest gain since 2022, putting the Federal Reserve's October 27-28 meeting squarely in focus after its first rate hike in three years last month. What does the Fed do at its October meeting? Vote and explain your reasoning in the comments.

September CPI hit 3.7% and PPI jumped 6.3%, both hotter than expected. What does the Fed do at its October meeting?

Current Price	$8.88
Prev Close	$8.74
Open	$8.43
Dividend Yield	0.00%
50-Day Moving Average	$9.34
Beta	2.52
Avg. Volume	3.88M
PE Ratio	-11.09

52-Week High	$12.06
52-Week Low	$2.24
Market Capitalization	$1.5B
EPS (Annual)	-$0.8421
Price to Book	6.19
Revenue Per Employee	$20,000.00

Feed

News

Sentiment

Earnings

Fundamentals

Info

ABSI Fundamentals